| Literature DB >> 33656449 |
Rosemary Saunders1, Karla Seaman1, Laura Emery1, Max Bulsara2, Catherine Ashford3, Judith McDowall3, Karen Gullick3, Beverley Ewens1, Trudy Sullivan4, Charlotte Foskett3, Lisa Whitehead1.
Abstract
BACKGROUND: The role of eHealth programs to support patients through surgical pathways, including total hip arthroplasty (THA), is rapidly growing and offers the potential to improve patient engagement, self-care, and outcomes.Entities:
Keywords: eHealth program; economic evaluation; education; hip arthroplasty; rehabilitation
Year: 2021 PMID: 33656449 PMCID: PMC8082385 DOI: 10.2196/22944
Source DB: PubMed Journal: JMIR Rehabil Assist Technol ISSN: 2369-2529
Figure 1CONSORT (Consolidated Standards of Reporting Trials) flow diagram of patients participating in the study.
Baseline demographics of participants in the intervention and control groups.
| Characteristics | Intervention (n=50) | Control (n=49) | ||
|
| .76a | |||
| Male | 26 (52) | 24 (49) | ||
| Female | 24 (48) | 25 (51) | ||
| Age (years), mean (SD) | 61.7 (12.1) | 64.6 (9.7) | .20b | |
|
| .69a | |||
| 60 | 20 (40) | 16 (33) | ||
| 61-70 | 17 (34) | 17 (34) | ||
| ≥71 | 13 (26) | 16 (33) | ||
| RAPTc score, mean (SD) | 10.5 (1.2) | 10.6 (1.3) | .79b | |
|
| >.99d | |||
| Additional interventions needed before discharge directly home (score 6-9) | 7 (14) | 6 (12) | ||
| Discharge directly home (score 10-12) | 43 (86) | 42 (86) | ||
| Missing | 0 | 1 (2) | ||
|
| .42d | |||
| Left THRe | 21 (42) | 22 (45) | ||
| Right THR | 29 (58) | 25 (51) | ||
| No surgery | 0 | 2 (4) | ||
|
| .18d | |||
| Posterior | 26 (52) | 19 (39) | ||
| Anterior | 23 (46) | 24 (49) | ||
| SUPERPATH | 1 (2) | 4 (8) | ||
| No surgery | 0 | 2 (4) | ||
| Length of stay (days), mean (SD) | 3.9 (1.5) | 3.7 (1.2) | .46b | |
| Attended education class, n (%) | 25 (50) | 26 (53) | .76a | |
| Known readmission, n (%) | 4 (8) | 2 (4) | .68d | |
aChi-square test.
bIndependent t test.
cRAPT: risk assessment and prediction tool.
dFisher exact test.
eTHR: total hip replacement.
Primary outcome assessment Hip Dysfunction and Osteoarthritis Outcome Score.
| Time periods | Intervention | Control | Difference | ||||
| Mean (SD) | n (%) | Mean (SD) | n (%) | ||||
|
| |||||||
| Symptoms | 49.48 (18.28) | 47 (100) | 43.38 (20.34) | 47 (100) | 6.10 (−1.82 to 14.02) | .13 | |
| Pain | 51.49 (12.41) | 47 (100) | 45.33 (14.07) | 46 (98) | 6.16 (0.70 to 11.62) |
| |
| Activities of daily living | 56.44 (15.50) | 47 (100) | 47.78 (14.86) | 47 (100) | 8.67 (2.44 to 14.88) |
| |
| Sport/recreation | 35.99 (23.45) | 47 (100) | 30.34 (19.93) | 46 (98) | 5.65 (−3.32 to 14.62) | .21 | |
| Quality of life | 30.72 (17.57) | 47 (100) | 27.26 (16.09) | 47 (100) | 3.46 (−3.44 to 10.36) | .32 | |
|
| |||||||
| Symptoms | 27.42 (21.01) | 37 (95) | 31.62 (25.17) | 41 (95) | −4.20 (−14.71 to 6.32) | .43 | |
| Pain | 30.07 (19.41) | 37 (95) | 33.00 (18.67) | 40 (95) | −2.93 (−11.58 to 5.72) | .50 | |
| Activities of daily living | 23.43 (16.23) | 37 (95) | 27.44 (20.38) | 41 (95) | −4.02 (−12.39 to 4.35) | .34 | |
| Sport/recreation | 18.24 (26.49) | 37 (95) | 21.19 (30.9) | 40 (95) | −2.95 (−16.07 to 10.16) | .66 | |
| Quality of life | 28.72 (21.72) | 37 (95) | 27.74 (26.45) | 41 (95) | 0.97 (−10.01 to 11.96) | .86 | |
|
| |||||||
| Symptoms | 32.68 (23.01) | 39 (93) | 37.53 (28.41) | 37 (100) | −4.85 (−16.64 to 6.94) | .42 | |
| Pain | 36.6 (17.5) | 39 (93) | 39.65 (21.62) | 36 (97) | −3.05 (−12.07 to 5.97) | .50 | |
| Activities of daily living | 28.56 (18.67) | 39 (93) | 35.13 (23.35) | 37 (100) | −6.57 (−16.21 to 3.07) | .18 | |
| Sport/recreation | 32.53 (30.29) | 39 (93) | 39.70 (32.01) | 36 (97) | −7.17 (−21.50 to 7.17) | .32 | |
| Quality of life | 39.42 (24.72) | 39 (93) | 42.91 (26.4) | 37 (100) | −3.48 (−15.16 to 8.19) | .55 | |
|
| |||||||
| Symptoms | 34.36 (22.97) | 32 (97) | 41.25 (24.61) | 39 | −6.89 (−18.25 to 4.48) | .23 | |
| Pain | 38.52 (19.01) | 32 (97) | 40.72 (18.88) | 38 | −2.21 (−11.27 to 6.86) | .63 | |
| Activities of daily living | 30.71 (19.50) | 32 (97) | 37.55 (19.76) | 39 (100) | −6.84 (−16.19 to 2.50) | .15 | |
| Sport/recreation | 40.04 (31.74) | 32 (97) | 44.19 (28.30) | 38 | −4.15 (−18.47 to 10.17) | .57 | |
| Quality of life | 45.12 (27.39) | 32 (97) | 47.44 (22.75) | 39 (100) | −2.34 (−14.19 to 9.55) | .70 | |
aIndependent t test.
bP value in italics are statistically significant.
Secondary outcome assessment 5-level 5-dimension quality of life measure.
| Time periods | Intervention | Control | Difference | ||||
| Mean (SD) | n (%) | Mean (SD) | n (%) | ||||
|
| |||||||
| Index | 0.64 (0.19) | 47 (100) | 0.59 (0.21) | 47 (100) | 0.05 (−0.03 to 0.14) | .20 | |
| VASb | 64.79 (20.02) | 47 (100) | 68.55 (18.23) | 47 (100) | −3.77 (−11.62 to 4.09) | .34 | |
|
| |||||||
| Index | 0.17 (0.20) | 37 (95) | 0.19 (0.26) | 42 (98) | −0.02 (−0.12 to 0.09) | .77 | |
| VAS | 10.43 (15.05) | 37 (95) | 10.52 (15.73) | 42 (98) | −0.09 (−7.01 to 6.83) | .98 | |
|
| |||||||
| Index | 0.21 (0.21) | 40 (95) | 0.23 (0.21) | 37 (100) | −0.02 (−0.11 to 0.08) | .72 | |
| VAS | 12.82 (20.08) | 39 (93) | 9.76 (15.05) | 37 (100) | 3.06 (−5.08 to 11.21) | .46 | |
|
| |||||||
| Index | 0.22 (0.18) | 32 (97) | 0.27 (0.22) | 39 (100) | −0.05 (−0.15 to 0.05) | .29 | |
| VAS | 15.77 (16.90c) | 31 (94) | 13.23 (13.21) | 39 (100) | 2.54 (−4.63 to 9.72) | .48 | |
aIndependent t test.
bVAS: visual analogue scale.
cLarge outlier (−62)—intervention participant (ID#51) not included.
Secondary outcome assessment self-efficacy for managing chronic disease score; per-protocol analysis.
| Time Periods | Intervention | Control | Difference between groups | |||
| Mean (SD) | n (%) | Mean (SD) | n (%) | |||
| Baseline/preadmissiona | 6.52 (1.88) | 47 (100) | 6.60 (1.80) | 47 (100) | −0.07 (−0.82 to 0.69) | .86 |
| Change baseline—6 weeksa | 1.29 (2.09) | 37 (35) | 1.51 (1.70) | 42 (98) | −0.22 (−1.06 to 0.63) | .62 |
| Change baseline—3 monthsa | 1.85 (2.06) | 41 (98) | 1.49 (1.67) | 37 (100) | 0.36 (−0.49 to 1.21) | .40 |
| Change baseline—6 monthsa | 2.06 (2.24) | 32 (97) | 1.76 (1.61) | 39 (100) | 0.31 (−0.61 to 1.22) | .51 |
aIndependent t test.
Satisfaction survey results by group.
| Survey questions | Control group (n=43), n (%) | Intervention group (n=39), n (%) | ||
|
| .34 | |||
| Strongly disagree | 0 (0) | 0 (0) | ||
| Somewhat disagree | 2 (4.6) | 0 (0) | ||
| Neither agree nor disagree | 1 (2.3) | 0 (0) | ||
| Somewhat agree | 11 (25.6) | 8 (20.5) | ||
| Strongly agree | 29 (67.4) | 31 (79.5) | ||
|
| .15 | |||
| Strongly disagree | 3 (7.0) | 0 (0) | ||
| Somewhat disagree | 0 (0) | 0 (0) | ||
| Neither agree nor disagree | 0 (0) | 0 (0) | ||
| Somewhat agree | 12 (27.9) | 8 (20.5) | ||
| Strongly agree | 28 (65.1) | 31 (79.5) | ||
|
| .51 | |||
| Strongly disagree | 2 (4.65) | 0 (0) | ||
| Somewhat disagree | 0 (0) | 1 (2.6) | ||
| Neither agree nor disagree | 2 (4.65) | 1 (2.6) | ||
| Somewhat agree | 12 (27.9) | 10 (25.6) | ||
| Strongly agree | 27 (62.8) | 27 (69.2) | ||
|
| .42 | |||
| Strongly disagree | 1 (2.3) | 0 (0) | ||
| Somewhat disagree | 2 (4.6) | 0 (0) | ||
| Neither agree nor disagree | 3 (7) | 1 (2.6) | ||
| Somewhat agree | 5 (11.6) | 6 (15.4) | ||
| Strongly agree | 32 (74.4) | 32 (82) | ||
|
| .70 | |||
| Strongly disagree | 2 (4.6) | 0 (0) | ||
| Somewhat disagree | 1 (2.3) | 1 (2.6) | ||
| Neither agree nor disagree | 2 (4.6) | 1 (2.6) | ||
| Somewhat agree | 11 (25.6) | 10 (25.6) | ||
| Strongly agree | 27 (62.8) | 27 (69.2) | ||
|
| .80 | |||
| Strongly disagree | 2 (4.7) | 1 (2.6) | ||
| Somewhat disagree | 0 (0) | 0 (0) | ||
| Neither agree nor disagree | 4 (9.3) | 2 (5.1) | ||
| Somewhat agree | 12 (27.9) | 10 (25.6) | ||
| Strongly agree | 25 (58.1) | 26 (66.7) | ||
aChi-square test.